Abstract Library

#4186 The effect of the Covid-19 pandemic on the body composition of patients with gastroenteropancreatic neuroendocrine tumors using a somatostatin analogue

Introduction: The Covid-19 pandemic and its restrictions had a negative impact on the general population. Due to lockdowns, food intake increased and exercise decreased. This led to weight gain and changes in body composition. Hospitals reviewed patients (pts) remotely. The effect of the Covid-19 pandemic has not been described in pts with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with somatostatin analogue (SSA).

Conference:

Presenting Author: Clement D

Authors: Clement D, Brown S, Dolly S, Mestre-Alagarda C, Giovos G,

Keywords: GEP-NET, SSA, malnutrition, Covid-19 pandemic,

#3874 Ileum NET lost to follow-up due to COVID-19 pandemic presents with multiple metastases and severe carcinoid syndrome

Introduction: Small bowel neuroendocrine tumors (NETs) arise from the diffuse neuroendocrine system. These are often diagnosed as a result of acute symptomatology such as bowel obstruction and are the most common cause of carcinoid syndrome (CS) due to liver metastases (LM).

Conference:

Presenting Author:

Authors: Diculescu R, Becheanu G, Croitoru A, Poiana C,

Keywords: neuroendocrine tumor, carcinoid syndrome, carcinoid heart disease, Octreotide,

#3839 The impact of the COVID-19 pandemic on neuroendocrine tumor (NET) service recovery and patient perceptions in Sheffield NET Centre UK – A quantitative and qualitative analysis 2017-2021

Introduction: The COVID-19 pandemic has affected the delivery of NET services and patient care. To assess the evolution of NET services during and peri-pandemic, we retrospectively analysed NET services and patient perceptions between 2017-2021.

Conference:

Presenting Author: Munir A

Authors: Munir A, Dabke T, Finnen J,

Keywords: COVID-19, NET, Service, Patient Satisfaction, Therapy, Psychology,

#3268 Management and treatment of neuroendocrine tumors during the global COVID-19 pandemic - Experience of medical oncology department of hospital 1st November

Introduction: The current recommendations for management of neuroendocrine tumor diseases are still evolving, due to the limited experience on this issue. As the new coronavirus can be transmitted through breath droplets, by contact, there is no consensus of how this fact may affect the investigation and treatment of neuroendocrine tumor diseases.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Bengueddach A, Kaid M, Kehili H, Tidjene A, Bereksi Reguig F,

Keywords: neuroendocrine, covid-19, treatment,

#3266 The psychological impact of COVID-19 pandemic in patients with NETs: Between resilience and vulnerability

Introduction: The COVID-19 pandemic has dramatically changed lifestyles and quality of life (QoL) of the global population. Little is known regarding the psychological impact of COVID-19 in patients with gastroenteropancreatic (GEP) or bronchopulmonary (BP) NETs.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Lauricella E

Authors: Lauricella E, Cives M, Bracigliano A, Lamia S, Felici V,

Keywords: covid-19, net, depression, anxiety, quality of life,